Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ DPYSL3 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5100454

Catalog No. PIPA5100454


Only null left
Add to Cart

Description

Description

Antibody detects endogenous levels of total CRMP4.

DPYSL3 is necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. DPYSL3 plays a role in axon guidance, neuronal growth cone collapse and cell migration.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DPYSL3
Polyclonal
Unconjugated
DPYSL3
Collapsin response mediator protein 4; collapsin response mediator protein 4 long; Crmp4; CRMP-4; dihydropyrimidinase like 3; dihydropyrimidinase-like 3; dihydropyrimidinase-related protein 3; Dpysl3; DRP3; DRP-3; LCRMP; testicular secretory protein Li 7; TOAD-64/Ulip/CRMP; TOAD-64/Ulip/CRMP protein 4b; TUC4; tuc-4; TUC-4b; ULIP; Ulip1; ULIP-1; Unc-33-like phosphoprotein 1
Rabbit
Affinity Chromatography
RUO
1809, 22240, 25418
-20°C
Liquid
Western Blot
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q14195, Q62188, Q62952
DPYSL3
A synthesized peptide derived from human DPYSL3(Accession Q14195), corresponding to amino acid residues G497-E547.
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.